Aura Biosciences Inc.
7.72
0.16 (2.12%)
At close: Jan 15, 2025, 3:59 PM
7.73
0.13%
After-hours Jan 15, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 1.29M 1.18M 835.00K 831.00K 509.00K
Gross Profit -1.29M -1.18M -835.00K -831.00K -509.00K
Operating Income -84.99M -60.30M -35.25M -22.21M -24.14M
Interest Income n/a 1.86M 13.00K 3.00 5.00
Pretax Income -76.27M -58.76M -35.25M -22.21M -24.20M
Net Income -76.41M -57.23M -34.42M -22.21M -24.20M
Selling & General & Admin 19.76M 18.06M 10.09M 4.16M 4.52M
Research & Development 63.94M 42.24M 25.16M 18.04M 19.62M
Other Expenses n/a -5.00K -11.00K 3.00K -44.00K
Operating Expenses 84.99M 60.30M 35.25M 22.21M 24.14M
Interest Expense n/a n/a 13.00K 3.00K 5.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 84.99M 60.30M 35.25M 22.21M 24.14M
Income Tax 137.00K -1.53M -830.00K 3.00K 5.00K
Shares Outstanding (Basic) 39.62M 29.94M 29.21M 29.22M 29.22M
Shares Outstanding (Diluted) 39.62M 29.94M 29.21M 29.22M 29.22M
EPS (Basic) -1.93 -1.91 -1.18 -0.76 -0.83
EPS (Diluted) -1.93 -1.91 -1.18 -0.76 -0.83
EBITDA -83.70M -59.12M -34.42M -21.38M -23.63M
Depreciation & Amortization 1.29M 1.18M 835.00K 831.00K 509.00K